# A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706

> **NCT03235362** · PHASE1 · COMPLETED · sponsor: **Yuhan Corporation** · enrollment: 28 (actual)

## Conditions studied

- Dyslipidemia
- Type 2 Diabetes Mellitus

## Interventions

- **DRUG:** YHR1705
- **DRUG:** YHR1706
- **DRUG:** YHR1705+YHR1706

## Key facts

- **NCT ID:** NCT03235362
- **Lead sponsor:** Yuhan Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-08-07
- **Primary completion:** 2017-09-19
- **Final completion:** 2017-09-19
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2017-11-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03235362

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03235362, "A Clinical Trial to Investigate the Pharmacokinetic Drug Interaction Between YHR1705 and YHR1706". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03235362. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*